華檢醫療(01931.HK)啓動"IVDNewCo Exchange"全球首個聚焦醫療創新藥NewCo高科技資產的RWA交易所生態及"IVDD"穩定幣計劃
格隆匯7月17日丨華檢醫療(01931.HK)公告,公司正積極推進一項具有里程碑意義的戰略舉措,即構建以醫療創新藥高科技資產爲核心的"NewCo+RWA"Web3交易所生態(下稱"本生態"),該生態將命名爲"IVDNewCo Exchange"(下稱"交易所"),並配套發行專有穩定幣(IVDDollar)("IVDD")。
本戰略旨在顛覆傳統醫藥行業發展規則,通過整合Web3技術(包括RWA真實世界資產代幣化、區塊鏈交易及穩定幣機制),提升全球醫療創新藥資產的流動性、融資效率及可及性。以下將詳細闡述本生態的戰略構想、進展、自身優勢及未來規劃。
戰略意義:IVDNewCo Chain生態體系不是簡單的技術應用,而是對醫療創新藥行業的價值鏈重構。它通過Web3解決行業痛點—顯著降低融資成本、加速新藥上市週期、並實現全球資源最優配置。董事會堅信"NewCo+RWA"Web3交易所生態運作模式將徹底改寫醫療創新藥行業的資本效率與全球化進程。透過結合頂級IP資源、全球合規網絡及Web3技術,華檢醫療有望開創一條全新的發展路徑,爲股東、全球投資者創造長期價值。
公司一直積極探索新商機及可能,務求爲股東帶來更高回報。集團將根據香港聯合交易所有限公司證券上市規則(如適用)要求適時就集團發展作出公告。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.